Cargando…

SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia

The emerging coronavirus disease 2019 (COVID-19) has become a serious global public health threat. With more and more recovered patients, it is urgently needed for evaluation of the neutralizing antibody (NAb) in these patients. In this study, we collected blood samples from 49 patients recently rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wei, Zhang, Jie, Qin, Xijian, Wang, Weixiao, Xu, Miaomiao, Wang, Lin-Fa, Xu, Chuanjun, Tang, Shuangshuang, Liu, Pei, Zhang, Libo, Liu, Xuan, Zhang, Yongchen, Yi, Changhua, Hu, Zhiliang, Yi, Yongxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Masson SAS. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425713/ https://www.ncbi.nlm.nih.gov/pubmed/33406577 http://dx.doi.org/10.1016/j.biopha.2020.110629

Ejemplares similares

An unusual COVID-19 case with over four months of viral shedding in the presence of low neutralizing antibodies: a case report
por: Chen, Wei, et al.
Publicado: (2020)

Clinical features and high-resolution chest computerized tomography findings of children infected by the B.1.617.2 variant of coronavirus disease 2019
por: Xu, Chuanjun, et al.
Publicado: (2022)

Impact of inactivated COVID-19 vaccines on viral shedding in B.1.617.2 (Delta) variant-infected patients
por: Hu, Zhiliang, et al.
Publicado: (2022)

Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy—a case report
por: Hu, Zhiliang, et al.
Publicado: (2020)

Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression
por: Hu, Zhiliang, et al.
Publicado: (2020)

Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19
por: Zhang, Libo, et al.
Publicado: (2020)

Antiresistin Neutralizing Antibody Alleviates Doxorubicin-Induced Cardiac Injury in Mice
por: Hu, Yewen, et al.
Publicado: (2022)

Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohort
por: Zhu, Liguo, et al.
Publicado: (2023)

Identification of broad neutralizing antibodies against Omicron subvariants from COVID-19 convalescents and vaccine recipients
por: Chen, Jun, et al.
Publicado: (2023)

Correlation between the IgG/IgA Antibody Response against PEDV Structural Protein and Virus Neutralization
por: Song, Xu, et al.
Publicado: (2023)

Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal Antigenemia
por: Xu, Miaomiao, et al.
Publicado: (2020)

Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant–infected patients in Jiangsu, China
por: Hu, Zhiliang, et al.
Publicado: (2022)

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2
por: Yi, Changhua, et al.
Publicado: (2020)

Molecular mechanism of antibody neutralization of coxsackievirus A16
por: Zhang, Chao, et al.
Publicado: (2022)

Structural basis for neutralization of an anicteric hepatitis associated echovirus by a potent neutralizing antibody
por: Feng, Rui, et al.
Publicado: (2021)

A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus
por: Du, Ruikun, et al.
Publicado: (2017)

Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China
por: Hu, Zhiliang, et al.
Publicado: (2020)

Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
por: Zhou, Zeqi, et al.
Publicado: (2021)

Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients
por: Lai, Miao, et al.
Publicado: (2023)

Protecting against different subtypes of influenza viruses: a nanoparticle approach
por: Yi, Changhua, et al.
Publicado: (2020)

Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines
por: Liu, Jianyang, et al.
Publicado: (2022)

Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice
por: Li, Yaohui, et al.
Publicado: (2020)

Viral neutralization by antibody-imposed physical disruption
por: Zheng, Qingbing, et al.
Publicado: (2019)

Metagenomic Next-Generation Sequencing vs. Traditional Microbiological Tests for Diagnosing Varicella-Zoster Virus Central Nervous System Infection
por: Zhu, Yunqi, et al.
Publicado: (2022)

Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016)

Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
por: Liu, Kuan-Ting, et al.
Publicado: (2022)

Serotype specific epitopes identified by neutralizing antibodies underpin immunogenic differences in Enterovirus B
por: Wang, Kang, et al.
Publicado: (2020)

Development of a sensitive monoclonal antibody-based sandwich ELISA to detect Vip3Aa in genetically modified crops
por: Liu, Weixiao, et al.
Publicado: (2020)

Detection of Neutralizing Antibodies to Tembusu Virus: Implications for Infection and Immunity
por: Lv, Junfeng, et al.
Publicado: (2019)

Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein
por: Hao, Meng, et al.
Publicado: (2020)

A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
por: Zhong, Ling, et al.
Publicado: (2022)

Reliability of Pseudotyped Influenza Viral Particles in Neutralizing Antibody Detection
por: Yang, Jinghui, et al.
Publicado: (2014)

Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A
por: Zhong, Yanwei, et al.
Publicado: (2011)

Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia
por: Qu, Jiuxin, et al.
Publicado: (2013)

Symptomatic and Asymptomatic SARS-CoV-2 Infection and Follow-up of Neutralizing Antibody Levels
por: CUI, Shu Juan, et al.
Publicado: (2022)

Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies
por: Ai, Yuanbao, et al.
Publicado: (2022)

Identification and characterization of a neutralizing monoclonal antibody that provides complete protection against Yersinia pestis
por: Liu, Weicen, et al.
Publicado: (2017)

Analysis of Cross-Reactive Antibodies Recognizing the Fusion Loop of Envelope Protein and Correlation with Neutralizing Antibody Titers in Nicaraguan Dengue Cases
por: Lai, Chih-Yun, et al.
Publicado: (2013)

Circulating CXCR3(+) Tfh cells positively correlate with neutralizing antibody responses in HCV-infected patients
por: Zhang, Jian, et al.
Publicado: (2019)

Treatment with broadly neutralizing influenza antibodies reduces severity of secondary pneumococcal pneumonia in mice
por: van Someren Gréve, Frank, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jj7s92lluiqb1lo1jpfdf6p3vd